New Volga fetal Rh test completes clinical trials and seeks to go global

New Volga fetal Rh test completes clinical trials and seeks to go globalScientists in Samara and Ulyanovsk, in the mid-Volga area, have developed a fetal Rh factor identification method «unparalleled elsewhere in Russia? and enabling early-stage fetus sex determination

Scientists in Samara and Ulyanovsk, in the mid-Volga area, have developed a fetal Rh factor identification method enabling early-stage fetus sex determination, Russian news agency ITAR-TASS reported, citing Andrei Redkin, the CEO of the Ulyanovsk Tech Transfer Center. The researchers are said to have come up with ?two unique test methods, one helping determine the sex of a baby starting from the seventh week of pregnancy, and the other pinpointing the fetus? Rh factor starting from the tenth week.? The testing is expected to be fairly affordable for patients (no more than $45/test). The new product will be found at Russian labs in the first six months of this year already. With the new development physicians are believed to be able to help women avoid what?s called Rh sensitization when mother has an Rh+ factor and baby has Rh-, or vice versa. Such a situation can cause the woman to miscarry...